Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ingo Hartlapp"'
Autor:
Friedrich, Anger, Johan Friso, Lock, Ingo, Klein, Ingo, Hartlapp, Armin, Wiegering, Christoph-Thomas, Germer, Volker, Kunzmann, Stefan, Löb
Publikováno v:
Annals of Surgical Oncology. 29:8523-8533
Background Pancreatic adenocarcinoma (PDAC) patients with preoperative carbohydrate antigen 19-9 (CA19-9) serum levels higher than 500 U/ml are classified as biologically borderline resectable (BR-B). To date, the impact of cholestasis on preoperativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f19ca772b863dbaba081a225502261b
https://doi.org/10.1245/s10434-022-12460-w
https://doi.org/10.1245/s10434-022-12460-w
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 3, Pp 648-655 (2014)
The prognosis of patients with locally advanced pancreatic cancer can be improved if secondary complete (R0) resection is possible. In patients initially staged as unresectable this may be achieved with neoadjuvant treatment which is usually chemorad
Externí odkaz:
https://doaj.org/article/6259161704de4c2d834dca5721ef6a71
Autor:
Friedrich, Anger, Johan Friso, Lock, Ingo, Klein, Ingo, Hartlapp, Armin, Wiegering, Christoph-Thomas, Germer, Volker, Kunzmann, Stefan, Löb
Publikováno v:
Annals of Surgical Oncology. 29:8534-8535
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ab229e259bb6aefc4a404b712ab2f2
https://doi.org/10.1245/s10434-022-12581-2
https://doi.org/10.1245/s10434-022-12581-2
Autor:
Helmut Friess, Dirk Waldschmidt, Holger Schulz, Martin Fuchs, Eray Goekkurt, Thomas Geer, Volker Heinemann, Wolfgang Blau, Marcel Reiser, Metin Senkal, Uwe Pelzer, Ralf Jakobs, Michael Stahl, Matthias Egger, Swantje Held, Jens T. Siveke, Ralph Keller, Christina Große-Thie, Thomas J. Ettrich, Stefan Boeck, Hubert J. Stein, Ingo Hartlapp, Georg Maschmeyer, Peter Fix, Thomas Südhoff, U. Lindig, Elke Hennes, Marcus Bahra, Volker Kunzmann, Ingo Klein, Frank Kullmann, Gabriele Margareta Siegler, Christoph Kahl, Hana Algül, Christoph-Thomas Germer, Uwe M. Martens, Stefan Mahlmann
Summary Background The optimal preoperative treatment for locally advanced pancreatic cancer is unknown. We aimed to compare the efficacy and safety of nab-paclitaxel plus gemcitabine with nab-paclitaxel plus gemcitabine followed by fluorouracil, leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1066cfe3208263c113f5fd0c464ccbd8
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148
Autor:
Ingo Hartlapp
This chapter gives an overview of the most important clinical presentations involving the gastrointestinal (GI) tract commonly seen in the field, including hepatitis, cirrhosis, peptic ulcer disease, and GI bleeding, from typical clinical presentatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9862716897e6fc73fded8708cdc05e59
https://doi.org/10.1093/med/9780199565276.003.0038
https://doi.org/10.1093/med/9780199565276.003.0038
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 7, Iss 3, Pp 648-655 (2014)
Case Reports in Oncology, Vol 7, Iss 3, Pp 648-655 (2014)
The prognosis of patients with locally advanced pancreatic cancer can be improved if secondary complete (R0) resection is possible. In patients initially staged as unresectable this may be achieved with neoadjuvant treatment which is usually chemorad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea750a9c5c0bbd6ebb32a0f4159c806
http://europepmc.org/articles/PMC4209279
http://europepmc.org/articles/PMC4209279
Autor:
Ingo Hartlapp, Michael Scheurlen, Volker Kunzmann, Justus Müller, Christoph-Thomas Germer, C. Isbert, Hermann Einsele, Ulrich Steger, Werner Kenn
Publikováno v:
Oncology Research and Treatment. 36:123-125
Background: Unresectable locally advanced pancreatic cancer (LAPC) has an extremely poor prognosis. Results of neoadjuvant (radio-)chemotherapy approaches aiming at achieving resectability are currently not satisfactory. Case Report: We report the ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5171dedc581939207bd13d74386e5a
https://doi.org/10.1159/000348527
https://doi.org/10.1159/000348527
Autor:
Rubina W. Saeed, Richard Bucala, Christine N. Metz, Wolfgang Voelter, Tina Peng, Ingo Hartlapp, Riichiro Abe
Publikováno v:
The FASEB Journal. 15:2215-2224
Angiogenesis is an ordered process requiring the inter-play of numerous cellular and humoral factors. Studies over the past 20 years have identified several growth factors, cytokines, and enzymes that promote blood vessel formation. Most have reveale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c38ba9063c0fe01bafcbb5b239d49b9
https://doi.org/10.1096/fj.01-0049com
https://doi.org/10.1096/fj.01-0049com
Autor:
Ingo Hartlapp, Andrea Kemkers, Ganna Weibert, Christian P. Pallasch, Daniel Re, Michael Hummel
Publikováno v:
Leukemia research. 33(7)
A variety of genetic and epigenetic abnormalities were characterized over the last years in Hodgkin and Reed-Sternberg (H-RS) cells of classic Hodgkin Lymphoma (cHL). It was speculated that simultaneous inhibition of multiple signalling pathways migh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0386f1af7979250a75e784127dc404a
https://pubmed.ncbi.nlm.nih.gov/19233468
https://pubmed.ncbi.nlm.nih.gov/19233468
Publikováno v:
Leukemialymphoma. 49(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe8eb1061f87324a02c18f7e2af21121
https://pubmed.ncbi.nlm.nih.gov/18231929
https://pubmed.ncbi.nlm.nih.gov/18231929